Pyrimidine metabolism, Inosine-uridine preferring nucleoside hydrolase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
GO:0005829 | cytosol | 2 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A0A3Q8INW1
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 7 |
GO:0006152 | purine nucleoside catabolic process | 6 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009116 | nucleoside metabolic process | 4 | 1 |
GO:0009164 | nucleoside catabolic process | 5 | 1 |
GO:0019439 | aromatic compound catabolic process | 4 | 1 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 1 |
GO:0034656 | nucleobase-containing small molecule catabolic process | 4 | 1 |
GO:0042278 | purine nucleoside metabolic process | 5 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044282 | small molecule catabolic process | 3 | 1 |
GO:0046700 | heterocycle catabolic process | 4 | 1 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 1 |
GO:0072521 | purine-containing compound metabolic process | 4 | 1 |
GO:0072523 | purine-containing compound catabolic process | 5 | 1 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 1 |
GO:1901136 | carbohydrate derivative catabolic process | 4 | 1 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 1 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
GO:1901657 | glycosyl compound metabolic process | 4 | 1 |
GO:1901658 | glycosyl compound catabolic process | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 7 |
GO:0016787 | hydrolase activity | 2 | 7 |
GO:0016798 | hydrolase activity, acting on glycosyl bonds | 3 | 7 |
GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds | 4 | 7 |
GO:0008477 | purine nucleosidase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.312 |
CLV_NRD_NRD_1 | 76 | 78 | PF00675 | 0.491 |
CLV_PCSK_KEX2_1 | 76 | 78 | PF00082 | 0.451 |
CLV_PCSK_SKI1_1 | 217 | 221 | PF00082 | 0.490 |
CLV_PCSK_SKI1_1 | 319 | 323 | PF00082 | 0.452 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.537 |
DOC_MAPK_DCC_7 | 217 | 226 | PF00069 | 0.237 |
DOC_MAPK_DCC_7 | 49 | 59 | PF00069 | 0.298 |
DOC_MAPK_gen_1 | 18 | 28 | PF00069 | 0.405 |
DOC_MAPK_MEF2A_6 | 167 | 175 | PF00069 | 0.237 |
DOC_MAPK_MEF2A_6 | 76 | 83 | PF00069 | 0.236 |
DOC_PP4_FxxP_1 | 132 | 135 | PF00568 | 0.201 |
DOC_USP7_MATH_1 | 141 | 145 | PF00917 | 0.278 |
DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.237 |
DOC_USP7_MATH_1 | 213 | 217 | PF00917 | 0.175 |
DOC_USP7_MATH_1 | 277 | 281 | PF00917 | 0.210 |
DOC_USP7_UBL2_3 | 142 | 146 | PF12436 | 0.219 |
DOC_WW_Pin1_4 | 125 | 130 | PF00397 | 0.313 |
DOC_WW_Pin1_4 | 313 | 318 | PF00397 | 0.234 |
DOC_WW_Pin1_4 | 60 | 65 | PF00397 | 0.290 |
LIG_14-3-3_CanoR_1 | 217 | 222 | PF00244 | 0.303 |
LIG_14-3-3_CanoR_1 | 267 | 272 | PF00244 | 0.245 |
LIG_14-3-3_CanoR_1 | 296 | 304 | PF00244 | 0.214 |
LIG_14-3-3_CanoR_1 | 319 | 325 | PF00244 | 0.290 |
LIG_BRCT_BRCA1_1 | 143 | 147 | PF00533 | 0.224 |
LIG_Clathr_ClatBox_1 | 221 | 225 | PF01394 | 0.237 |
LIG_Clathr_ClatBox_1 | 333 | 337 | PF01394 | 0.271 |
LIG_eIF4E_1 | 31 | 37 | PF01652 | 0.226 |
LIG_FHA_1 | 114 | 120 | PF00498 | 0.292 |
LIG_FHA_1 | 268 | 274 | PF00498 | 0.273 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.313 |
LIG_LIR_Apic_2 | 131 | 135 | PF02991 | 0.179 |
LIG_LIR_Gen_1 | 144 | 152 | PF02991 | 0.287 |
LIG_LIR_Gen_1 | 232 | 242 | PF02991 | 0.242 |
LIG_LIR_Gen_1 | 287 | 297 | PF02991 | 0.237 |
LIG_LIR_Gen_1 | 327 | 336 | PF02991 | 0.273 |
LIG_LIR_Nem_3 | 144 | 150 | PF02991 | 0.287 |
LIG_LIR_Nem_3 | 232 | 238 | PF02991 | 0.242 |
LIG_LIR_Nem_3 | 287 | 293 | PF02991 | 0.246 |
LIG_LIR_Nem_3 | 327 | 333 | PF02991 | 0.242 |
LIG_NRBOX | 32 | 38 | PF00104 | 0.226 |
LIG_PCNA_PIPBox_1 | 1 | 10 | PF02747 | 0.527 |
LIG_PCNA_yPIPBox_3 | 66 | 77 | PF02747 | 0.260 |
LIG_Pex14_2 | 28 | 32 | PF04695 | 0.290 |
LIG_SH2_CRK | 235 | 239 | PF00017 | 0.201 |
LIG_SH2_CRK | 290 | 294 | PF00017 | 0.237 |
LIG_SH2_NCK_1 | 290 | 294 | PF00017 | 0.273 |
LIG_SH2_SRC | 201 | 204 | PF00017 | 0.175 |
LIG_SH2_STAP1 | 115 | 119 | PF00017 | 0.291 |
LIG_SH2_STAP1 | 235 | 239 | PF00017 | 0.303 |
LIG_SH2_STAP1 | 278 | 282 | PF00017 | 0.237 |
LIG_SH2_STAT3 | 65 | 68 | PF00017 | 0.252 |
LIG_SH2_STAT3 | 72 | 75 | PF00017 | 0.257 |
LIG_SH2_STAT5 | 115 | 118 | PF00017 | 0.395 |
LIG_SH2_STAT5 | 188 | 191 | PF00017 | 0.343 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.317 |
LIG_SH2_STAT5 | 209 | 212 | PF00017 | 0.245 |
LIG_SH2_STAT5 | 290 | 293 | PF00017 | 0.273 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.290 |
LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.252 |
LIG_SH3_3 | 236 | 242 | PF00018 | 0.242 |
LIG_SUMO_SIM_anti_2 | 50 | 56 | PF11976 | 0.308 |
LIG_SUMO_SIM_par_1 | 222 | 227 | PF11976 | 0.276 |
LIG_SUMO_SIM_par_1 | 50 | 56 | PF11976 | 0.263 |
LIG_SUMO_SIM_par_1 | 82 | 87 | PF11976 | 0.252 |
LIG_TRFH_1 | 200 | 204 | PF08558 | 0.175 |
MOD_CDK_SPxK_1 | 313 | 319 | PF00069 | 0.219 |
MOD_CK1_1 | 124 | 130 | PF00069 | 0.342 |
MOD_CK1_1 | 240 | 246 | PF00069 | 0.271 |
MOD_CK1_1 | 248 | 254 | PF00069 | 0.279 |
MOD_CK1_1 | 265 | 271 | PF00069 | 0.237 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.552 |
MOD_GlcNHglycan | 313 | 316 | PF01048 | 0.456 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.314 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.215 |
MOD_GSK3_1 | 224 | 231 | PF00069 | 0.227 |
MOD_GSK3_1 | 237 | 244 | PF00069 | 0.213 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.218 |
MOD_GSK3_1 | 284 | 291 | PF00069 | 0.235 |
MOD_GSK3_1 | 302 | 309 | PF00069 | 0.160 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.337 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.211 |
MOD_LATS_1 | 215 | 221 | PF00433 | 0.237 |
MOD_N-GLC_1 | 302 | 307 | PF02516 | 0.437 |
MOD_NEK2_1 | 289 | 294 | PF00069 | 0.290 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.363 |
MOD_NEK2_2 | 141 | 146 | PF00069 | 0.237 |
MOD_NEK2_2 | 325 | 330 | PF00069 | 0.193 |
MOD_PKA_2 | 266 | 272 | PF00069 | 0.260 |
MOD_PKA_2 | 284 | 290 | PF00069 | 0.358 |
MOD_Plk_1 | 224 | 230 | PF00069 | 0.206 |
MOD_Plk_4 | 217 | 223 | PF00069 | 0.296 |
MOD_Plk_4 | 325 | 331 | PF00069 | 0.207 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.250 |
MOD_ProDKin_1 | 125 | 131 | PF00069 | 0.308 |
MOD_ProDKin_1 | 313 | 319 | PF00069 | 0.234 |
MOD_ProDKin_1 | 60 | 66 | PF00069 | 0.290 |
MOD_SUMO_for_1 | 194 | 197 | PF00179 | 0.237 |
MOD_SUMO_rev_2 | 197 | 207 | PF00179 | 0.175 |
TRG_DiLeu_BaEn_2 | 154 | 160 | PF01217 | 0.237 |
TRG_ENDOCYTIC_2 | 235 | 238 | PF00928 | 0.201 |
TRG_ENDOCYTIC_2 | 260 | 263 | PF00928 | 0.242 |
TRG_ENDOCYTIC_2 | 290 | 293 | PF00928 | 0.237 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.290 |
TRG_ER_diArg_1 | 295 | 298 | PF00400 | 0.237 |
TRG_NLS_MonoExtN_4 | 15 | 22 | PF00514 | 0.514 |
TRG_Pf-PMV_PEXEL_1 | 71 | 75 | PF00026 | 0.449 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P506 | Leptomonas seymouri | 55% | 99% |
A0A0S4JP56 | Bodo saltans | 22% | 78% |
A4I1X0 | Leishmania infantum | 100% | 100% |
E9AY16 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4Q9F7 | Leishmania major | 93% | 100% |